The mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa is regulated by the NfxB repressor. Two forms of NfxB have been reported [Shiba et al. (1995) . J Bacteriol 177, 5872) although mutagenesis studies here confirm that the larger protein (199 amino acids, 22.4 kDa) is the functional repressor. NfxB binds upstream of the mexCD-oprJ transcription initiation site to a region containing two inverted repeats, both of which are required for binding. Two-hybrid assays confirmed that NfxB is a multimer, with the C-terminal two-thirds of the repressor required for multimerization. Random mutagenesis identified several mutations within the C-terminal region of NfxB required for multimerization, all of which mapped to a three-helix subdomain of the C-terminal region in a structural model of the repressor, which may thus represent the multimerization domain. These mutations compromised NfxB binding to its target DNA in electromobility shift assays, and their introduction into the chromosome of P. aeruginosa enhanced mexCD-oprJ expression and promoted multidrug resistance, consistent with the functional NfxB repressor being a multimer. Site-directed and spontaneous nfxB mutants showing increased mexCD-oprJ expression and multidrug resistance were also recovered, with mutations mapping to the three-helix subdomain again impacting multimerization and DNA binding. Mutations mapping to the N-terminal helix-turn-helix motif implicated in DNA binding did not impact multimerization although they did render the repressor insoluble and unsuitable for mobility shift assays. Size exclusion column chromatography demonstrated that wild-type NfxB forms tetramers in solution, although a mutant form of the repressor carrying a G192D substitution near the C terminus of the protein and compromised for DNA binding and repressor activity forms dimers. These results suggest that NfxB operates as a tetramer (dimer of dimers) and that the C terminus of the protein serves as a tetramerization domain.
INTRODUCTION
Multidrug efflux systems of the resistance-nodulationdivision (RND) family are important determinants of antimicrobial resistance in Pseudomonas aeruginosa (Poole, 2011) . While 11 RND family efflux systems have been described in this organism (Poole, 2012) only four have been linked to clinically relevant resistance -MexABOprM, MexXY-OprM, MexEF-OprN and MexCD-OprJ (Poole, 2011) . Quiescent in wild-type cells grown under standard laboratory conditions, MexCD-OprJ does not contribute to intrinsic antimicrobial resistance in P. aeruginosa (Srikumar et al., 1997) , although its hyperexpression in so-called nfxB mutants is responsible for acquired multidrug resistance in this organism (Poole et al., 1996) . The pump accommodates a broad range of antimicrobials, including fluoroquinolones (FQs), b-lactams, macrolides, tetracyclines, chloramphenicol (Poole et al., 1996) , tigecycline (Dean et al., 2003) , biocides [e.g. triclosan (Chuanchuen et al., 2001 ) and chlorhexidine (Fraud et al., 2008) ], organic solvents (Li et al., 1998) , dyes and detergents (Srikumar et al., 1997 ), with FQs (Join-Lambert et al., 2001 Köhler et al., 1997; Mandsberg et al., 2011) , macrolides (e.g. azithromycin) (Mulet et al., 2009) and triclosan (Chuanchuen et al., 2001) readily selecting mexCD-oprJ-hyperexpressing mutants resistant to these agents. While this efflux system has been implicated in FQ resistance in clinical isolates (Poole, 2000; Reinhardt et al., 2007; Zhanel et al., 2004) , mexCD-oprJ-expressing mutants appear to be rare in a clinical setting (Jeannot et al., 2008; Kiser et al., 2010) . Similarly, although MexCDOprJ accommodates cefepime (Masuda et al., 2000) it is seldom linked to resistance to this agent in clinical isolates (Jeannot et al., 2008) . Azithromycin induction of mexCDoprJ expression has been reported in biofilms (Gillis et al., 2005) and mutants lacking both MexCD-OprJ and MexAB-OprM are unable to form biofilms in the presence of azithromycin, suggesting that MexCD-OprJ is involved in azithromycin tolerance in biofilm cells (Gillis et al., 2005) . Consistent with this, azithromycin readily selects MexCD-OprJ-expressing nfxB mutants in biofilm-grown P. aeruginosa (Mulet et al., 2009) . MexCD-OprJ also accommodates experimental antimicrobials, including CHIR-090, an inhibitor of the lipid A synthetic enzyme LpxC, and this compound selects nfxB mutants in vitro (Caughlan et al., 2012) .
Despite its contribution to antimicrobial resistance, MexCD-OprJ is generally inducible by membrane-damaging agents, including several biocides (e.g. chlorhexidine), dyes, detergents, organic solvents and cationic antimicrobial peptides (Fraud et al., 2008; Morita et al., 2003) , consistent with envelope stress being a signal for MexCD-OprJ recruitment. In agreement with this, and with MexCD-OprJ functioning as part of an envelope stress response in P. aeruginosa, membrane-damaging agent induction of mexCD-oprJ is mediated by the algUencoded envelope stress response sigma factor (Fraud et al., 2008) , a functionally equivalent homologue of Escherichia coli RpoE (Yu et al., 1995) that was first described as a regulator of alginate biosynthesis in P. aeruginosa (Hershberger et al., 1995; Martin et al., 1993) . MexCDOprJ contributes to intrinsic and acquired chlorhexidine resistance -mutants lacking the pump are chlorhexidinesensitive while nfxB mutants hyperexpressing MexCDOprJ are resistant to this biocide (Fraud et al., 2008) . MexCD-OprJ has also been linked to high-level acquired chlorhexidine resistance in vitro (Fraud et al., 2008) and chlorhexidine tolerance in biofilms (Chiang et al., 2012) .
Expression of mexCD-oprJ is controlled by a single known regulator, the NfxB repressor (Poole et al., 1996; Shiba et al., 1995) , encoded by the nfxB gene, which is transcribed divergently from the efflux genes (Poole et al., 1996) . In vitro-selected (Hirai et al., 1987; Masuda et al., 1995; Poole et al., 1996) and clinical (Henrichfreise et al., 2007; Higgins et al., 2003; Jakics et al., 1992; Jalal & Wretlind, 1998; Jalal et al., 2000; Yoshida et al., 1994) isolates expressing this efflux system and resistant to FQs invariably contain mutations in nfxB (Henrichfreise et al., 2007; Jalal & Wretlind, 1998; Jalal et al., 2000; Higgins et al., 2003; Poole et al., 1996) . MexCD-OprJ-hyperexpressing mutants selected by azithromycin (Mulet et al., 2009) and triclosan (Chuanchuen et al., 2001 ) also invariably contain mutations in nfxB. Two NfxB products have been reported, of 21 and 23 kDa molecular mass (Shiba et al., 1995) , and although the functional repressor has not been confirmed the nfxB gene is annotated as producing a 21 kDa product (http://www.Pseudomonas.com). The current study was undertaken to define the functional nfxB gene and to identify functionally important residues in NfxB. We confirm here that the NfxB repressor is the larger, approximately 23 kDa product, and we identify several residues in the protein whose mutation compromises NfxB multimerization and DNA binding.
METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . Bacterial cells were cultured in Luria broth (L-broth) and on L-agar with antimicrobials, as necessary, at 37 uC. Plasmids pEX18Tc and pMS604 and their derivatives were maintained in E. coli with tetracycline (10 mg ml
21
). Plasmid pK18mobsacB and its derivatives were maintained in E. coli with kanamycin (50 mg ml
). Plasmid pET23a and its derivatives were maintained in E. coli with ampicillin (100 mg ml 21 ). Plasmid pAK1900 and its derivatives were maintained in E. coli with ampicillin (100 mg ml 21 ) and in P. aeruginosa strain K1542 with carbenicillin (5 mg ml 21 ). pNFX-1, a pAK1900 derivative carrying the nfxB gene on a 2.2 kb insert, has been described previously (Poole et al., 1996) and was used in the mutagenesis of the two possible ATG start codons (to GCG; Ala) identified upstream of this gene (Shiba et al., 1995) . Sitedirected mutagenesis was carried out using the QuikChange Lightening Site-Directed Mutagenesis kit (Agilent Technologies) according to the protocol provided by the manufacturer, with an annealing temperature of 62 uC and an extension time of 4 min for the amplification. Mutagenesis of the more distal ATG (encoding residue M1) was achieved using the primers SDM-nfxB-M1AF (59-AGTTTTCTGCACAGCGCGCACAATCAGA-39; mutant codon in bold type and mutated bases underlined) and SDM-nfxB-M1AR (59-TCTGATTGTGCGCGCTGTGCAGAAAACT-39; mutant codon complementary sequence in bold type and mutated bases underlined) while mutagenesis of the more proximal ATG (encoding M13) was achieved using primers SDM-nfxB-M13AF (59-GGACCCATCGGC-GACCCTGATTTCC-39) and SDM-nfxB-M13AR (59-GGAAATCAG-GGTCGCCGATGGGTCC-39), yielding plasmids pACP110 and pACP111, respectively. Plasmid pACP112, a pAK1900 derivative carrying nfxB on a smaller (700 bp) fragment, was constructed by cloning a PCR-generated product amplified from P. aeruginosa K767 chromosomal DNA using primers nfxB-longF (59-ACTGAAGCTT-TAATTCCTTTGGACGCGA-39; HindIII site underlined) and nfxBlongR (59-GGTTGGATCCTGATCTTCCCGAGTGTCG-39; BamHI site underlined). The 50 ml PCR mixture contained 1 mg chromosomal DNA, 1 mM each primer, 0.3 mM each deoxynucleoside triphosphate (dNTP), 16 GC Phusion polymerase buffer and 1 U Phusion DNA polymerase (New England Biolabs). Following an initial denaturation step at 98 uC for 3 min, the mixture was subjected to 30 cycles of 98 uC for 30 s, 62 uC (annealing temperature) for 30 s and 72 uC for 45 s, before finishing with a 10 min incubation at 72 uC. The nfxB-containing PCR product was gel-purified (see below), digested with HindIII and BamHI, and cloned into HindIII-BamHI-restricted pAK1900.
DNA methods. Standard protocols were used for restriction endonuclease digestion, ligation, transformation, plasmid isolation, agarose gel electrophoresis, and preparation of chemically competent (CaCl 2 ) E. coli cells (Sambrook & Russell, 2001 ). Electrocompetent P. aeruginosa cells were prepared as described by Choi et al., (2006) . Chromosomal DNA was extracted from P. aeruginosa using the DNeasy Blood and Tissue kit (Qiagen). Plasmid DNA was prepared from E. coli using a GeneJET Plasmid Miniprep kit (Fermentas) according to a protocol provided by the manufacturer. The Wizard SV Gel and PCR Clean-Up System kit (Promega) was used to purify PCR products and to gel-purify DNA fragments generated by restriction endonuclease digestion. Oligonucleotides were synthesized by Integrated DNA Technologies and nucleotide sequencing was performed by ACGT (Toronto, Ontario). Studier (1991) A. Purssell and K. Poole
Construction of an nfxB deletion strain. A vector-borne nfxB deletion tagged with a gentamicin resistance (Gm R ) gene was engineered on plasmid pEX18Tc using a previously described overlapping PCR approach in which the Gm R gene from plasmid pPS856 was inserted between two 500 bp fragments corresponding to sequences upstream and downstream of the nfxB gene. The nfxB upstream and downstream regions were amplified with 1 U Vent polymerase (New England Biolabs) from P. aeruginosa K767 genomic DNA (1 mg) in a 50 ml reaction containing 16 Thermopol buffer, 10 % (v/v) DMSO, 0.3 mM dNTPs and 1 mM primer pairs nfxB-UF (59-AACCGGATCCTCGATCTGGAACAGC-AGG-39; BamHI site underlined) and nfxB-UR-Gm (59-TCAGAG-CGCTTTTGAAGCTAATTCGGGGAAATCAGGGTCATCG-39) (for the upstream region), or nfxB-DF-Gm (59-AGGAACTTCAAGATC-CCCAATTCGTACCCTGGAGCAGATGTTC-39) and nfxB-DR (59-AACCAAGCTTCATCAACAGGACCAGCAA-39; HindIII site underlined) (for the downstream sequence). Following an initial denaturation step of 3 min at 95 uC, each mixture was subjected to 30 cycles of heating at 95 uC for 30 s, 58 uC for 30 s, and 72 uC for 1 min, before finishing with a 10 min incubation at 72 uC. The Gm R cassette was amplified from plasmid pPS856 as described by . The nfxB upstream and downstream fragments were then fused to the Gm R cassette using PCR in a 50 ml reaction mixture containing 16 HF Phusion polymerase buffer, 50 ng each of the nfxB upstream and downstream fragments and the Gm R cassette, 3 % (v/v) DMSO, 3.5 mM MgCl 2 , 0.3 mM dNTPs and 1 U Phusion DNA polymerase. After an initial 3 min incubation at 95 uC and three cycles of 95 uC for 1 min, 55 uC for 1 min and 72 uC for 1 min, 1 mM each of the primers nfxB-UF and nfxB-DR was added. The reaction was subjected to another 25 cycles of 95 uC for 1 min, 63 uC for 1 min and 72 uC for 5 min, and then a final 5 min incubation at 72 uC. The 2 kb PCR product obtained was agarose gel-purified, digested with BamHI and HindIII and cloned into BamHI-HindIIIrestricted pEX18Tc to create the DnfxB : : Gm R plasmid pACP109. The pACP109 insert was sequenced to ensure no errors had been introduced during PCR, and pACP109 was subsequently mobilized into P. aeruginosa K767 from E. coli S17-1 via conjugation (Sobel et al., 2003) . Transconjugants were selected on gentamicin (50 mg ml 21 )-containing L-agar and then streaked on 10 % (w/v) sucrose Lagar plates supplemented with 50 mg gentamicin ml 21 . The Gm R cassette was excised using Flp recombinase as described by and a K767 derivative lacking nfxB, K2951, was identified using colony PCR (Sheu et al., 2000) with primers nfxB-UF and nfxB-DR, and 30 cycles of heating at 95 uC for 30 s, 58 uC for 30 s and 72 uC for 2 min, before finishing with a 10 min incubation at 72 uC.
Generation of nfxB missense mutants. Spontaneous nfxB derivatives of P. aeruginosa K1542 were selected on L-agar containing erythromycin (128 mg ml 21 ) and subsequently screened for reduced susceptibility to the MexCD-OprJ substrate antimicrobials ciprofloxacin, cefepime and erythromycin. The nfxB genes of mutants showing enhanced resistance to all three antimicrobials were amplified and sequenced to identify the mutation responsible. Several additional nfxB mutations, including one (G192D) identified previously (Mulet et al., 2009) , were also engineered into P. aeruginosa K1542 by first cloning nfxB into plasmid pEX18Tc and subjecting it to site-directed mutagenesis before subcloning the mutant nfxB genes into plasmid pK18mobsacB and mobilizing them into strain K1542. Initially, then, a 2 kb fragment encompassing nfxB was amplified using primers swi-nfxB-F (59-ACACGGATCCAT-CGAAGTCCTGCTGGCT-39; BamHI site underlined) and swi-nfxB-R (59-ACACAAGCTTCAGGGTCAGGTAGAGGGAT-39; HindIII site underlined) and Phusion DNA polymerase as above except that an annealing temperature of 65 uC was employed and DMSO (3 %, v/v) was included. The nfxB-carrying PCR product was gel-purified, digested with BamHI and HindIII and cloned into a BamHI-HindIIIrestricted pEX18Tc to form pACP100. Missense mutations of nfxB were then introduced into pACP100 using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies) according to the protocol provided by the manufacturer, using primers SDM-nfxB-H99RF (59-GCAGCGCCTGATCAAGGAACGCCTCACCCACCGC-GAGCTGC-39) and SDM-nfxB-H99RR (59-GCAGCTCGCGGTG-GGTGAGGCGTTCCTTGATCAGGCGCTGC-39) (for NfxB H99R ), SDM-nfxB-F147SF (59-GGACAGCAGAAAGGCGTGTCTCGCATC-GACATCACGGCG-39) and SDM-nfxB-F147SR (59-CGCCGTGAT-GTCGATGCGAGACACGCCTTTCTGCTGTCC-39) (for NfxB F147S ), and SDM nfxB G192DF (59-GAGCAGATGTTCCTCCATGACG-CCTCCAATCCGGCTCGC-39) and SDM nfxB G192DR (59-GCG-AGCCGGATTGGAGGCGTCATGGAGGAACATCTGCTC-39) (for NfxB G192D ), an extension time of 4.5 min and an annealing temperature of 60 uC (for NfxB H99R ) or 62 uC (for NfxB F147S and NfxB G192D ). Mutant nfxB-carrying fragments were excised from these pACP100 derivatives using BamHI and HindIII and cloned into pK18mobsacB, which was then mobilized into P. aeruginosa K1542 from E. coli S17-1 as above. P. aeruginosa harbouring chromosomal inserts of these pK18mobsacB derivatives were selected on L-agar containing kanamycin (600 mg ml 21 ) and subsequently patched onto L-agar containing sucrose (10 %, w/v). Sucrose-resistant colonies were then screened on ciprofloxacin (0.5 mg ml 21 ) and cefepime (1 mg ml 21 ) L-agar plates to identify colonies harbouring the nfxB mutations. The nfxB genes of these were amplified using primers nfxB-long-F and nfxB-long-R and PCR as above and then sequenced to confirm the presence of the expected nfxB mutation.
Screening PCR-mutagenized nfxB for mutations abrogating NfxB-NfxB self-association. Error-prone PCR mutagenesis was performed on the nfxB-carrying plasmid pACP114 in a 50 ml PCR mixture containing 1 ml pACP114 as template, 1 mM each of the primers nfxB-Orig-pMS604F (59-GATCGGTGACCATGACCCTGA-TTTCCCATGAC-39; BstEII site underlined) and nfxB-pMS604R §pEX18Tc, pK18mobsacB and pET23a plasmids carrying an nfxB gene encoding wild-type (WT) or mutant NfxB proteins (amino acid changes highlighted in parentheses). ||pNFX-1 derivatives in which two putative nfxB Met start codons, M1 and M13 (most distal Met numbered 1), are individually mutated to Ala. #pACP112 derivatives carrying nfxB encoding mutant NfxB proteins (amino acid changes highlighted in parentheses). **pMS604 derivatives carrying full-length (bp 1-600) or truncated (as indicated; gene end points indicated prior to semi-colon) nfxB genes encoding WT (M1-S199) and truncated (as indicated; first and last amino acids indicated after semi-colon) NfxB proteins. (59-ACACCAGCTGTCAGGAGCGAGCCGGATT-39; PvuII site underlined), 0.3 mM each dNTP, 16 Thermopol buffer, and 5 U Taq DNA polymerase (New England Biolabs). Following an initial denaturation step at 95 uC for 3 min, the mixture was subjected to 30 cycles of heating at 95 uC for 30 s, 62 uC for 30 s and 72 uC for 1 min, before finishing with a 10 min incubation at 72 uC. The mutagenized nfxB PCR products were digested with BstEII and PvuII and cloned into BstEII-PvuII-restricted pMS604 before being transformed into E. coli SU101, which was then plated on MacConkey agar plates supplemented with lactose. Colonies that appeared red on the MacConkey agar plates (i.e. b-galactosidasepositive), indicative a lack of NfxB-NfxB self-association, were recovered and the pMS604-resident nfxB genes sequenced. Production of NfxB-LexA fusion proteins and loss of self-association was confirmed using immunoblotting and a b-galactosidase assay, respectively, as described below.
Assay for assessing NfxB-NfxB self-association. To assess a potential NfxB-NfxB interaction and the possible negative impact of nfxB mutations or truncations on that interaction, wild-type, mutated and truncated nfxB was cloned into plasmid pMS604 and introduced into E. coli SU101 as before (Nehme et al., 2004) . The wild-type nfxB gene was amplified from P. aeruginosa K767 chromosomal DNA using primers nfxB-FL-pMS604F (59-ACACGGTGACCATGCGCA-CAATCAGAAAAACC-39; BstEII site underlined) and nfxB-pMS604R (59-ACACCAGCTGTCAGGAGCGAGCCGGATT-39; PvuII site underlined) and Phusion DNA polymerase as described above for nfxB cloned into pAK1900, to generate pACP112. Truncated nfxB variants nfxB 37-600 (NfxB M13-S199 ; amplified with nfxB-Orig0-pMS604F and nfxB-pMS604R), nfxB 177-600 [NfxB R59-S199 ; amplified with nfxB-R59-pMS604F (59-ACACGGTGACCCGGGACAACCTGGTGCAG-39; BstEII site underlined) and nfxB-pMS604R], nfxB 238-600 [NfxB A80-S199 ; amplified with nfxB-MC-pMS604F (59-ACACGGTGACCGCCTG-CGACCTGGAGCAT-39; BstEII site underlined) and nfxB-pMS604R], nfxB 355-600 [NfxB D119-S199 ; amplified with nfxB-C-pMS604F (59-ACACGGTGACCGACCCGCACGGCGAAGGC-39; BstEII site underlined) and nfxB-pMS604R] and nfxB 1-372 [NfxB M-G124 ; amplified with nfxB-FL-pMS604F and nfxB-NM-pMS604R (59-ACACCAGCTGT-GCCCTTCGCCGTGCGGGTC-39; PvuII site underlined)] were also engineered using the same PCR conditions. Finally, nfxB genes carrying randomly generated or site-directed missense mutations (see above) were amplified from the chromosome of various K1542 derivatives using primers nfxB-FL-pMS604F and nfxB-pMS604R, again using the same conditions. All nfxB-carrying fragments were then sequenced to ensure that no mutations had been introduced during the PCR, digested with BstEII and PvuII and cloned into BstEII-PvuII-restricted pMS604. The resultant pMS604 derivatives encoding fusions of wildtype, truncated or mutant NfxB to the DNA-binding domain of LexA were introduced into E. coli SU101, and production of NfxB-LexA fusion proteins was confirmed by immunoblotting (Srikumar et al., 1998) of whole-cell extracts (Rédly & Poole, 2003) prepared from exponential phase cells cultivated in L-broth containing chloramphenicol (10 mg ml
) and IPTG (1 mM) with anti-LexA antibodies (Abcam). Plasmid-bearing E. coli SU101 was then cultivated overnight in L-broth containing chloramphenicol (10 mg ml 21 ), diluted 1 : 49 into the same medium containing 1 mM IPTG, and grown to midexponential phase before being assayed for b-galactosidase activity as described by Miller (1992) . E. coli SU101 carries a lacZ gene under the control of an operator to which dimeric LexA can bind, and so dimerization of the LexA-binding domains promoted by the interaction of the NfxB proteins fused to them leads to repression of lacZ. Loss of or reduction in b-galactosidase activity is, thus, a measure of NfxB-NfxB interaction.
Expression and purification of polyhistidine (His)-tagged NfxB.
In order to facilitate the purification of NfxB, a C-terminal polyhistidine tag was engineered onto wild-type NfxB (NfxB WT -His) by cloning the wild-type nfxB gene into plasmid pET23a. The gene nfxB was amplified from P. aeruginosa K767 chromosomal DNA using Phusion DNA polymerase and primers Exp-nfxB-F (59-ACACCATATGCGCACAATCAGAAAAAC-39; NdeI site underlined) and Exp-nfxB-R (59-ACACAAGCTTGGAGCGAGCCGGATTGG-39; HindIII site underlined) as above for the construction of pACP112. The PCR product was digested with NdeI and HindIII and subsequently cloned into NdeI-HindIII-restricted-pET23a to produce the NfxB-His vector pACP118. pET23a derivatives expressing polyhistidine-tagged mutant NfxB proteins were generated using the same approach, except that chromosomal DNA from P. aeruginosa K1542 derivatives harbouring the desired nfxB mutations served as template for the PCR. All inserts in pET23a were sequenced to ensure that no additional mutations were introduced during PCR. Each of the NfxBHis vectors was introduced into E. coli BL21(DE3) carrying the pLysS plasmid, and induction and purification of the NfxB-His products were carried out using a modified version of a previously described protocol (Evans et al., 2001) . Overnight cultures of E. coli BL21 carrying pLysS and the appropriate nfxB-encoding pET23a vector grown in L-broth containing chloramphenicol (10 mg ml
) and tetracycline (10 mg ml 21 ) were subcultured 1 : 49 into the same medium and allowed to grow to OD 600 0.5-0.6 at 27 uC. Cultures were then supplemented with 1 mM IPTG (or 0.5 mM in the case of the NfxB S48R -expressing pET23a vector) to induce NfxB-His production and incubated for another 2 h at 27 uC. Cells were harvested by centrifugation (10 000 g for 10 min at 4 uC) and subsequently resuspended in 6 ml Buffer A (0.3 M NaCl, 50 mM Na 2 HPO 4 ) supplemented with 5 mM imidazole, 2.5 mM MgCl 2 and 0.5 mM CaCl 2 . After lysis of cells by sonication [3630 s at power setting 40 using a VibraCell Sonicator (Sonics & Materials)], cell lysates were pelleted by centrifugation (16 000 g, 60 min, 4 uC). The NfxB-His-containing supernatant was treated with 200 ml of a 1 mg ml 21 solution of DNase I (Sigma Aldrich) for 30 min at 20 uC, and then mixed with 500 ml Ni-NTA agarose resin (Qiagen) previously equilibrated with 10 ml Buffer A containing 5 mM imidazole. The NfxB-His-bound Ni-NTA agarose resin was washed three times with Buffer A containing 5 mM imidazole (10 ml for the first two washes and 2 ml for the final wash) and then once with 500 ml Buffer A supplemented with 50 mM imidazole. NfxB-His was then eluted with 500 ml Buffer A containing 300 mM imidazole. The eluted proteins were visualized using SDS-PAGE and quantified using a BCA Protein Assay kit (Pierce). Protein was stored at 280 uC in 10 % (v/v) glycerol.
Antimicrobial susceptibility testing. The antimicrobial susceptibilities of various P. aeruginosa strains were assessed in 96-well microtitre plates using twofold serial dilutions as described by Jo et al. (2003) .
Quantitative RT-PCR (qRT-PCR). Overnight L-broth cultures of P. aeruginosa strains were subcultured (1 : 49) in fresh L-broth and incubated at 37 uC while shaking for 2.5 h. Total bacterial RNA was isolated from 1 ml exponential-phase culture using the High Pure RNA Isolation kit (Roche Diagnostics) according to the protocol provided by the manufacturer. Samples were treated with Turbo DNA-Free (Ambion; 2 U enzyme per 50 ml sample for 45 min at 37 uC) and were subsequently tested for DNA contamination by PCR. RNA was converted into cDNA using the iScript cDNA Synthesis kit (Bio-Rad) according to the manufacturer's instructions. Quantitative RT-PCR of the cDNA was performed on a CFX96 Real-Time PCR Detection System (Bio-Rad) in 20 ml reaction mixtures consisting of 10 ml SsoFast EvaGreen Supermix (Bio-Rad), 0.6 mM each of the two primers corresponding to the gene being amplified [mexD, q-mexD-F (59-CTCGAGCTATACGTGCCTAAC-39) and q-mexD-R (59-GTCC-CTCTTCCCATTTCACG-39); rpsL, q-rpsL-F (59-GGCGTGCGTTA-CCACACCGT-39) and q-rpsL-R (59-GGACGCTTGGCGCCGTA-CTT-39)] and 5 ml of 1 : 24 diluted cDNA. After an initial 3 min denaturation, the mixture was subjected to 40 cycles of 10 s at 95 uC and 30 s at 60 uC. Following the completion of the 40 cycles, a melting curve was generated by denaturing the DNA for 10 s at 95 uC and then reducing the temperature by 0.5 uC every 5 s to ensure a unique PCR product was produced. Expression of mexD, normalized to rpsL, was calculated using the standard analysis feature of the CFXmanager software version 1.6 (Bio-Rad). Biological duplicates and technical replicates were performed for all samples and a no-template control was run to confirm a lack of genomic DNA contamination.
Electrophoretic mobility shift assay (EMSA). The interaction of NfxB and its mutant derivatives with the mexCD-oprJ regulatory region was assessed using an EMSA. A variety of DNA fragments encompassing portions of the mexCD-oprJ upstream region were employed as EMSA targets and were either amplified using Phusion DNA polymerase or constructed using complementary singlestranded synthetic oligonucleotides that were annealed to form double-stranded DNA targets. EMSA DNA fragments I (201 bp) and II (124 bp) were amplified with Phusion DNA polymerase as above using primer pairs EMSA-mexC-IF (59-TCATGGGAAATCAGG-GTCAT-39) and EMSA-mexC-IR (59-TATTGCACGCAAATCAG-CC39), and EMSA-mexC-IIF (59-TGTGCAGAAAACTGGCCT-39) and EMSA mexC-IIR (59-GACACACCCGACCGTTGA-39), and annealing temperatures of 56 and 60 uC, respectively. Fragments III (76 bp), IV (36 bp) and V (39 bp) were constructed by annealing oligonucleotides EMSA-mexC-III (59-GAATTAGCTGTCAAAAGA-TCATTTGAGACAATATTGACTCAATTAGCTCGAAAAAGTACCA-TTCGATCCGTTTTCA-39), EMSA-mexC-IV (59-GAATTAGCTGTC-AAAAGATCATTTGAGACAATATTG-39) and EMSA-mexC-V (59-C-TCAATTAGCTCGAAAAAGTACCATTCGATCCGTTTTCA-39), respectively, with corresponding reverse complementary oligonucleotides. This was achieved my mixing 25 ml of 500 ng ml 21 solutions of each oligonucleotide pair, heating at 90 uC for 5 min and then slowly cooling to 20 uC over 30 min. EMSAs were performed with purified NfxB and 50 ng target DNA using the Electrophoretic Mobility Shift Assay kit (Molecular Probes) according to the basic protocol supplied by the manufacturer (Starr et al., 2012) . Samples were run on 6 % (w/ v) non-denaturing polyacrylamide gels, stained with SYBR Green EMSA nucleic acid gel stain and photographed with an S6656 SYPRO filter (Molecular Probes).
Negative dominance assay. Selected nfxB genes harbouring missense mutations were individually cloned into pAK1900 as BamHI-HindIII fragments following their amplification with Phusion DNA polymerase and primers nfxB-long-F and nfxB-long-R as above. The resultant vectors were electroporated into P. aeruginosa K1542, and the mutant NfxBs were assessed for their ability to functionally disrupt mexCD-oprJ repression by the genomeencoded NfxB as measured by qRT-PCR. In preparing RNA for qRT-PCR (see above), overnight cultures (but not subcultures from which RNA was subsequently isolated) were supplemented with 5 mg carbenicillin ml 21 .
Mapping the mexCD-oprJ transcriptional start site. The mexCD-oprJ transcriptional start site was identified using the 59/39 RACE kit (2nd Generation; Roche Diagnostics) according to the manufacturer's instructions. Total RNA was extracted from the mexCD-oprJ-hyperexpressing P. aeruginosa nfxB strain K1536 cultured as above for qRT-PCR and reverse transcribed into cDNA using a kit-provided reverse transcriptase and a mexC-specific primer, CDJ-5RACE1 (59-ATCGAAGTCCTGCTGGCT-39; anneals 423 bp downstream of the mexC start codon), according to a protocol provided by the manufacturer. A homopolymeric A-tail was added to the 39 end of the resultant cDNA strand using terminal transferase, and the dAtailed cDNA subsequently PCR-amplified with Phusion polymerase in Phusion GC buffer as above (except for an annealing temperature of 61 uC) using the kit-provided oligo dT-anchor primer and a second mexC-specific primer, CDJ-5RACE2 (59-TCGATCTGGAACA-GCAGG-39; anneals 281 bp downstream of the mexC start codon).
The resulting PCR product was then used as template in a second PCR involving Phusion polymerase, the dT-anchor primer and a third mexC-specific primer, CDJ-5RACE3 (59-CACCGGCAAC-ACCATTTC-39; anneals 111 bp downstream of the mexC start codon), using the same PCR conditions but an annealing temperature of 56 uC. The final PCR product was incubated with Taq DNA polymerase (5 U) at 72 uC for 15 min to produce 59 dT extensions that permitted ready cloning (following purification of the PCR product) into the linearized vector pSTBlue-1 AccepTor (Novagen/ EMD Millipore) using instructions provided by the manufacturer. The resultant vector was sequenced and aligned against the PAO1 genome sequence of mexCD-oprJ to elucidate the transcriptional start site.
Size-exclusion chromatography. Analytical size-exclusion chromatography of NfxB and its missense mutant variants (600 mg in 1.5 ml) was carried out on a Superdex 200 10/300 GL column (GE Healthcare Bio-Sciences) connected to an Ä KTA fast protein liquid chromatographic system (GE Healthcare Bio-Sciences). Samples were run in the presence of Buffer A (see above under 'Expression and purification of polyhistidine (His)-tagged NfxB') at 0.5 ml min 21 , collected in 1 ml fractions, and analysed at 280 nm. Protein elution profiles were compared against elution profiles of protein standards [Bio-Rad Gel Filtration Standards: bovine c-globulin (158 kDa), chicken ovalbumin (44 kDa), horse myoglobin (17 kDa) and vitamin B 12 (1.35 kDa)] that were used to generate a standard curve, and fractions corresponding to the protein peaks were run on SDS-PAGE as described previously to confirm the presence of NfxB. Molecular masses (M) of proteins in peak fractions were determined using a plot of logM vs (V E 2V 0 )/(V C 2V 0 ), where V E is the elution volume, V 0 the void volume and V C the column volume.
Protein structure modelling. The NfxB model was based on the crystal structure of a probable transcriptional regulatory protein, RHA5900, from Rhodococcus jostii RHA1 (PDB code: 2IBD, chain B; 22.8 % amino acid sequence identity, 52.6 % similarly to NfxB) and was developed using the SWISS-MODEL server (Arnold et al., 2006) . The model was visually inspected and subjected to energy minimization using GROMOS (Christen et al., 2005) . The final model quality was evaluated using the QMEAN program (Benkert et al., 2008) , which yielded a QMEAN score of 0.646 and an estimated absolute quality (Zscore) of 21.25 (N.B. high resolution structures have, on average, Zscores of 0). A Ramachandran plot of the model (Deepview program; SWISS-MODEL server) indicated that 95.7 % of the modelled residues occurred in favoured regions, 2.7 % occurred in permitted regions and only 1.6 % in outlier regions. The final model was rendered for viewing using PyMol (PyMol Molecular Graphics System, version 1.5.0.4 Schrödinger; http://www. pymol.org).
RESULTS

Defining the functional nfxB gene
In an earlier report, functional nfxB that complemented an nfxB mutant strain K385, reversing the multidrug resistance of this mutant, resided on a 2.2 kb insert in plasmid pNFX-1 (Poole et al., 1996) . Attempts to localize the gene to a smaller fragment by assessing complementation of K385 by subcloning smaller nfxB-containing fragments into plasmid pRK415 were unsuccessful (inserts that carried less nfxB upstream sequence than was present on pNFX-1 did not restore the antimicrobial susceptibility of K385; data not shown). Subcloning nfxB into a different vector, pAK1900, however, allowed for complementation of K385 with inserts as small as 700 bp (Table S1 , available in Microbiology Online; see pACP112) and including only 35 bp of nfxB upstream sequence (Fig. 1) . The nfxB gene present on this insert has two possible start codons (initiator amino acids M1 and M13; Fig. 1 ), yielding proteins of 22 403 and 20 946 Da molecular mass, respectively, although the Pseudomonas Genome website defines the NfxB protein as beginning at M13 (http://www. pseudomonas.com). Moreover, the original nfxB publication identified two possible NfxB products, of 21 and 23 kDa molecular mass, although the functional gene product was not conclusively defined. To identify the functional NfxB protein, then, the M1-and M13-encoding start codons were individually mutated (to Ala) on plasmid pNFXB-1 and the impact on mexCD-oprJ expression (assessed using qRT-PCR; Fig. 2 ) and drug susceptibility (Table S1 ) of the NfxB 2 P. aeruginosa strain K385 assessed. While unaltered nfxB on pNFX-1 readily suppressed mexCD-oprJ expression (Fig. 2, lane 3) and restored the antimicrobial susceptibility of strain K385 to wild-type levels (Table S1 ), mutating the ATG codon encoding M1 obviated this suppression (Fig. 2, lane 4) and failed to enhance the antimicrobial susceptibility of strain K385 (Table S1 ; see pACP110). In contrast, mutating the second ATG start codon (encoding M13) still allowed for substantial repression of mexCD-oprJ (Fig. 2, lane 5) and restoration of antimicrobial susceptibility of K385 to wildtype levels (Table S1 ; see pACP111). Thus, functional NfxB is the larger product that initiates from M1.
Defining the NfxB-binding site upstream of mexCD-oprJ
A previous study confirmed the binding of NfxB to sequences upstream of the nfxB gene (Shiba et al., 1995) ( Fig. 3a ; fragment I), at the time being unaware that this corresponded to the nfxB-mexC intergenic region and so also included the probable mexCD-oprJ promoter. This was confirmed using 59-RACE where the mexCD-oprJ promoter was mapped to a cytosine 17 bp upstream of the mexC gene (Fig. 3a) . No obvious sigma-70 promoter sequence was identified upstream of mexC, suggesting that some other sigma factor promotes mexCD-oprJ transcription. Within the originally defined NfxB-binding region were two imperfect inverted repeats (IRs) that were implicated in NfxB binding (Shiba et al., 1995) . To localize the NfxB-binding site within the mexCD-oprJ upstream region, smaller fragments were assessed for NfxB binding using EMSA. A fragment (II; Fig. 3a) corresponding to the nfxB-mexC intergenic region readily bound NfxB (binding seen with as low as 100 ng NfxB ml
21
; Fig. 3b ), as did a smaller fragment (III; Fig. 3a ) that still encompassed both IRs (Fig. 3b) . Still, the proportion of unshifted target DNA remaining at 400 ng NfxB ml 21 was markedly greater for the smaller fragment III, indicating that, qualitatively, NfxB bound less well to this fragment and that optimal binding required the full intergenic region. To assess whether individual IRs were sufficient for NfxB binding, fragments carrying the first (IV) or second (V) IR only (Fig. 3a) were tested and no NfxB binding was observed (Fig. 3b) . Thus, both IRs were required for NfxB binding.
Impact of nfxB mutations on NfxB self-association
In light of the size of the mexCD-oprJ promoter region that was required for binding by NfxB it seemed likely that the repressor was functional as a multimer. To assess this, the wild-type nfxB gene was cloned into plasmid pMS604 and introduced into E. coli strain SU101, a reporter strain in which repression of the resident lacZ gene and, thus, reduced b-galactosidase activity is a measure of selfassociation of the product of the gene cloned into pMS604. Wild-type nfxB in pMS604 markedly reduced bgalactosidase activity of E. coli SU101 relative to this strain harbouring pMS604 without an insert (Fig. 4b) , consistent with the NfxB protein multimerizing. In an effort to define the region of NfxB required for this, truncated versions of nfxB were constructed in pMS604 and the ability of the truncated NfxB proteins to self-associate was assessed. Loss of the first 12 or 58 amino acids of NfxB had no impact on NfxB multimerization ( Fig. 4a ; see M13-S199 and R59-S199) or protein production/stability (Fig. 4c, lanes 2 and  7) while more extensive N-terminal truncations severely compromised NfxB levels/stability (Fig. 4c, lanes 3 and 4) and, so, NfxB multimerization is not possible ( Fig. 4a ; see A80-S199 and D119-S199). The R59 residue that marks the N-terminal end point of the largest truncation retaining NfxB multimerization capability occurs just downstream of a strongly predicted HTH motif implicated in DNA binding (Fig. 1) suggesting that the C-terminal region of NfxB, exclusive of its DNA-binding domain, is important for multimerization. Consistent with this, loss of the last 75 amino acids of NfxB also compromised NfxB multimerization ( Fig. 4a ; see M1-G124) while having a minimal impact on protein production/stability (Fig. 4c, lane 5) .
To more precisely define residues important for NfxB selfassociation, nfxB-carrying pMS604 was mutagenized and introduced into E. coli SU101, and b-galactosidase + colonies in which lacZ repression was lost (a measure of loss of NfxB self-association) selected on MacConkey agar. Following confirmation that b-galactosidase levels were increased in these colonies, production of NfxB products was confirmed using immunblots with anti-LexA antiserum, and the nfxB genes sequenced from recovered pMS604 plasmids. In this fashion four nfxB mutations were identified that compromised NfxB self-association, H99R, F147S, L100P and F156S (Fig. 4b, c, lanes 10, 11, 15 and 16 ), all located within the Cterminal half of the protein (Fig. 1) . Representatives of these (H99R and F147S) were subsequently engineered into the chromosome of P. aeruginosa strain K1542 and the impact on mexCD-oprJ expression and antimicrobial resistance assessed. As expected, expression (Fig. 5) and resistance (Table S2) increased markedly, consistent with the NfxB repressor functioning as a multimer.
Identification of mutations that obviate NfxB repressor activity
In order to identify additional residues important for NfxB repressor function, spontaneous nfxB mutants of strain K1542 were selected on L-agar containing the MexCDOprJ antimicrobial substrate erythromycin. Erythromycinresistant isolates were first screened for resistance to additional MexCD-OprJ substrate antimicrobials, and the nfxB genes of those exhibiting a multidrug resistance phenotype were amplified by PCR and sequenced. Frameshift and nonsense mutations were uncommon amongst the nfxB mutants obtained, with missense mutations, particularly in the stop codon and yielding an extended NfxB product, especially common (e.g. 12 of 28 nfxB mutants carried an A600C mutation in nfxB leading to a stop-Cys change in the protein and an additional 68 amino acids at the C terminus). This mutation, which provides for an approximate 90-fold increase in mexCDoprJ expression (Fig. 5) , has been described previously (Mulet et al., 2009) and is the mutation responsible for mexCD-oprJ hyperexpression in nfxB strain K1536 (Hirakata et al., 2002) . Three single amino acid missense mutations were also recovered, yielding NfxB products with S48R, K49Q and G166D changes, two of which (S48R, G166D) were studied further and shown to provide for increased mexCD-oprJ expression (Fig. 5 ) and multidrug resistance (Table S2 ). The S48R and K49Q mutations occurred within the aforementioned HTH DNA-binding motif (Fig. 1) and, as expected, the S48R mutation, as a representative of these HTH mutations, did not adversely impact NfxB multimerization (Fig. 4b) or NfxB production mexC Fig. 1 . Functionally important regions and residues of NfxB. The end points of Nterminally truncated NfxB constructs ending at S199 are indicated by forward arrows above the first amino acid residue in the constructs and the end point of a C-terminal truncation initiating at M1 is indicated by a reverse arrow above the final amino acid residue. Mutations in NfxB compromising repressor function are in bold type (no arrow) with those hindering NfxB multimerization boxed. Two potential ATG start codons for nfxB are highlighted in bold type as is the upstream end point of an nfxB subclone present in plasmid pACP112 (indicated by a downward arrow). A predicted N-terminal helix-turn-helix (HTH) DNA-binding motif in NfxB is italicized. ( Fig. 4c, lane 9) in the two-hybrid system. The G166D mutation had only a modest negative impact on NfxBNfxB interaction in the two-hybrid assay, with NfxB G166D multimerization still clearly evident (Fig. 4b) and, again, NfxB G166D was produced at wild-type levels (Fig. 4c, lane  12) . The minimal or no impact of the S48R and G166D mutations on NfxB-NfxB interaction indicated that they compromised some other feature of NfxB in interfering with its repressor activity. Consistent with this, and with the general lack of impairment in self-association, these variants interfered with the repressor activity of wild-type NfxB as seen in a negative dominance assay, increasing mexCD-oprJ expression approximately eightfold and fourfold, respectively, relative to wild-type NfxB (Fig. 6) . In contrast, those NfxB variants with defects in self-association (H99R, L100P, F147S and F156S) had no impact on wild-type NfxB repressor activity in this assay, consistent with their inability to interact (Fig. 4) .
While the mutations identified here as impacting NfxB repressor function covered a substantial portion of the gene, no mutations were found near the C terminus, in contrast with an earlier study where a G192D mutation (G180D in that paper, incorrectly using M13 as the NfxB start) was identified (Mulet et al., 2009) . To assess the impact of this latter mutation on mexCD-oprJ expression, antimicrobial resistance and NfxB self-association, it was engineered into the chromosome of P. aeruginosa strain K1542 and into the nfxB gene on plasmid pMS604. As expected, the NfxB G192D mutation promoted multidrug resistance (Table S2 ) and, intriguingly, provided for the highest level of mexCD-orpJ expression of any nfxB mutant examined (approx. 250-fold increase; Fig. 5 ), approaching that observed in an nfxB deletion strain (approx. 400-fold increase; Fig. 5 ). The mutation, which did not adversely affect NfxB production (Fig. 4c, lane 13) , also compromised NfxB multimerization (Fig. 4b) and so did not impact wild-type NfxB repressor activity in the negative dominance assay (Fig. 6 ).
Impact of nfxB mutations on NfxB DNA-binding activity
The representative nfxB mutations studied here ultimately compromised NfxB repressor activity leading to enhanced mexCD-oprJ expression and multidrug resistance, suggesting that they all compromised NfxB binding to its target DNA upstream of mexCD-oprJ. To assess this, the mutant NfxB proteins were expressed as His-tagged proteins and their ability to bind the mexCD-OprJ promoter region assessed using EMSA. While high-level production of NfxB S48R and NfxB H99R was achieved, these proteins readily and reproducibly precipitated, despite numerous attempts to increase and maintain their solubility, and, thus, their DNA-binding abilities could not be assessed. The F147S, G166D and G192D variants were all compromised for DNA binding (at 200 mg protein none of the variants showed evidence of binding, in contrast to wildtype NfxB; Fig. 7 , lane 4), though some binding was apparent at the highest protein levels tested (400 mg; Fig. 7 , lane 5). Interestingly, the magnitude of the shift seen for NfxB G192D was markedly less than that for the other variants or for wild-type NfxB (data not shown).
Impact of nfxB mutations on the oligomeric state of NfxB in solution
To gain some insight into the functional NfxB unit and how nfxB mutations were impacting this, the molecular masses of wild-type NfxB and its soluble variants, NfxB G166D and NfxB G192G , were determined using sizeexclusion chromatography (insufficient yields of NfxB F147S were recovered to permit its study here). The wild-type repressor yielded several peaks off the Superdex 200 10/300 GL column, with two of these containing NfxB (Fig. 8a) . The major NfxB peak was calculated to be 25.8 kDa, in good agreement with the predicted monomer molecular mass for NfxB (22.4 kDa), while the secondary NfxB peak was calculated to be 97.6 kDa, consistent with tetrameric NfxB. In contrast, NfxB G166D yielded a single NfxBcontaining peak (Fig. 8b) , of 19.5 kDa molecular mass, consistent with this variant forming a monomer only in solution. NfxB G192D yielded two NfxB-containing peaks (Fig. 8c) , of 19.5 kDa and 49.4 kDa molecular mass, indicative of monomeric and dimeric forms of this NfxB variant in solution. The lack of oligomers for NfxB G166D and the existence of NfxB G192D oligomers contrasted with the results of the two-hybrid assay, which showed evidence of self-association for NfxB G166D but not NfxB G192D . In any case, and unlike wild-type NfxB, these DNA-bindingdeficient NfxB variants failed to produce tetrameric NfxB, which may, thus, be the active DNA-binding repressor form of the protein.
Mapping function-altering mutations onto a structural model of NfxB
The identification of mutations compromising NfxB multimerization and/or DNA binding can be useful in defining functional domains of this repressor protein.
To this end, a structural model for an NfxB monomer was derived from the B chain of the dimeric protein Rha5900 of R. jostii as described in Methods, and the functioncompromising mutations mapped onto it (Fig. 9 ). The derived model reveals two discrete regions of the protein, a three-helix N-terminal domain that includes the presumed DNA-binding HTH motif (Fig. 9, a1-a3 ) and a five-helix C-terminal domain that forms the bulk of the protein (Fig.  9 , a4-a8) and contains a two-helix region that lacks any function-altering mutations (a4 and a6) adjacent to a three-helix region where all of the multimerizationinhibiting mutations occur (a5, a7 and a8). Interestingly, the R59 truncation site that defines the largest N-terminal truncation that still yields a stable, multimerization-capable NfxB derivative yields a protein that retains the entirety of the five-helix C-terminal domain. Destabilizing N-terminal truncations beginning at A80 or D119 map to one or the other of a4 and a5 of the NfxB structure and in common lack the first of these helices, suggesting that this two-helix region, while possibly lacking residues directly involved in NfxB-NfxB interaction, is vital to proper folding of the Cterminal multimerization domain. Intriguingly, all of the mutations that compromise NfxB multimerization (without compromising protein stability) map to the three-helix region at the left of the NfxB structure, which likely represents the multimerization domain proper of the protein. Consistent with this, the loss of the bulk of this region in the lone C-terminally truncated NfxB variant studied (C-terminal end point of G124) obviated the NfxB-NfxB interaction while having a minimal impact on protein stability. The G192 residue, whose mutation yielded a dimeric NfxB, occurs at the end of a8, at the extreme C terminus of the protein. This region of NfxB may, thus, function as a tetramerization domain. The G166D NfxB variant is an outlier of sorts in that it occurs within this three-helix region but has only a minimal impact on NfxB self-association.
DISCUSSION
Mutational analysis of NfxB identified a number of functionally important residues in this repressor that tended to occur in two regions of a structural model of NfxB, one near the N terminus and containing a DNAbinding HTH motif and the other near the C terminus and containing a three-helix subdomain implicated in protein oligomerization (Fig. 9) . Interestingly, a previous study of azithromycin-resistant mexCD-oprJ-expressing nfxB Expression of mexD (as a measure of mexCD-oprJ) was assessed in P. aeruginosa K1542 nfxB derivatives expressing the indicated NfxB variants using qRT-PCR. The results shown were normalized to strain K1542 expressing wild-type nfxB and are the mean±SD of three independent experiments. mutants (Mulet et al., 2009 ) also revealed that virtually all missense mutation-directed changes to the repressor mapped to the HTH region (L26P, L38P, L41P, A42V, T51I and R54L; residue numbering altered from the original paper to reflect correct translation initiation site for NfxB) or occurred within (L95P, G166D) or immediately adjacent to (L141P, L190P, G192D and S194P) the three-helix subdomain. Alterations to the two helices that link the N-and C-terminal domains were virtually absent in both of these studies, suggesting that they have a structural role only and that their mutational alteration fails to substantially alter NfxB oligomerization and DNA binding and so does not perturb NfxB repressor activity The three-dimensional model of an NfxB monomer, comprising eight a-helices (numbered sequentially), was created by homology modelling on the crystal structure of a probable transcriptional regulatory protein, RHA5900, from R. jostii RHA1 (PDB code 2IBD, chain B). Residues (shown in space fill) whose mutation negatively impacts NfxB multimerization are indicated with asterisks. The end points of truncations assessed for an impact of NfxB self-association (Fig. 4) are indicated by short lines on the structure and labelled with the residue that occurs at the site of the truncation. The HTH DNA-binding motif is darkened relative to the rest of the NfxB structure.
sufficiently to permit mexCD-oprJ expression at a level that promotes measurable antimicrobial resistance. Of the spontaneous nfxB mutants that were selected in the current study, almost all carried missense mutations, with the most common change in NfxB being a stop-C alteration that yielded an NfxB variant with an additional 68 residues at the C terminus. With one exception (G192D), all of the variants studied showed a moderate (30-to 90-fold increase relative to wild-type) hyperexpression of mexCD-oprJ that was substantially lower than was seen for an in vitroconstructed nfxB null mutant, indicating that these compromised but did not abrogate NfxB repressor activity. Consistent with this, representative NfxB variants of these missense mutants still bound to target DNA in vitro, although less well than wild-type NfxB. Our recovery of only a limited number of fully null nfxB mutants suggests that these are selected against or are unstable, and, indeed, we did observe that the nfxB deletion strain reverted to wild-type resistance and lost mexCD-oprJ hyperexpression during routine passage in the lab. This likely reflected some detrimental impact of excessive MexCD-OprJ expression and activity, possibly owing to excessive export of endogenous and needed substrates. Similarly, a previous report of mexCD-oprJ-hyperexpressing nfxB mutants recovered from a biofilm-grown population of P. aeruginosa highlighted the relative paucity of nfxB frameshift and nonsense mutations (Mulet et al., 2009) .
A previous study (Shiba et al., 1995) identified two IRs that occurred on the DNA fragment shown to bind NfxB (now known to be the nfxB-mexCD-oprJ intergenic region) and the IRs appear to be essential for this binding. IRs tend to bind dimeric regulators, suggesting that two NfxB dimers bind upstream of mexCD-oprJ. Consistent with this, NfxB appeared here to form tetramers in solution, although the bulk of the protein occurred as monomers. Whether this is an artefact of high-level in vitro expression of the protein, with NfxB monomers achieving a conformation in solution incompatible with oligomerization, or the protein generally favours monomers in solution but oligomerizes in producing a DNA-binding-competent form is unclear. There are a number of examples of bacterial regulatory proteins existing as monomers in solution but forming oligomers (typically dimers) when bound to DNA (Daddaoua et al., 2009; Kim & Little, 1992; Rhee et al., 2008; Singh et al., 2012) . It is also possible that the C-terminal polyhistidine tag incorporated into the NfxB repressor to assist its purification is adversely impacting oligomerization. The purified redox regulator Fnr of Bacillus cereus, like NfxB, has, for example, been shown to form monomers and oligomers in solution, with a polyhistidine tag apparently impeding oligomer formation (Esbelin et al., 2008) . Still, attempts to address the possibly negative impact of the C-terminal Histag on NfxB oligomerization, by engineering an N-terminal His-tagged protein, were unsuccessful owing to low yields of soluble N-terminally His-tagged NfxB (data not shown). In any case, our results suggest a correlation between tetramerization and repressor activity, and support NfxB functioning as a tetramer. In agreement with this, a mutation that abrogates NfxB tetramer formation in vitro (G192D) but produces dimeric (and monomeric) NfxB which binds mexCD-oprJ promoter less well and shows a noticeably smaller shift than does wild-type NfxB in EMSAs shows markedly elevated mexCD-oprJ expression. Indeed, this mutation produced the highest level of mexCD-oprJ expression of all the nfxB missense mutations that were studied here, surpassed only by that observed for the nfxB deletion. The extreme C terminus of NfxB may, thus, define a tetramerization domain. While dimeric regulators appear to be the norm in bacteria, there are several examples of tetrameric regulatory proteins, including the well-studied LacI (LacR) repressor of the lac operon in E. coli (Lewis et al., 1996) and members of the IclR (Lu et al., 2010; Zhang et al., 2002) and LysR-type transcriptional regulator (LTTR) (Monferrer et al., 2010; Muraoka et al., 2003) families.
It is curious that the NfxB F147S variant, though exhibiting a defect in oligomerization (as defined in the two-hybrid assay) and showing a reduced capacity for DNA binding, nonetheless shows a band shift reminiscent of the apparently tetrameric wild-type repressor. The F147S substitution occurs in a region of the NfxB model that is likely involved in dimerization, and the mutation may, thus, compromise dimer formation but not the potential for tetramer formation. Indeed, the LacI (LacR) repressor forms tetramers (a dimer of dimers), with different regions of the protein responsible for dimerization (Suckow et al., 1996) and tetramerization (Alberti et al., 1991) . Moreover, mutations that impede LacI (LacR) dimer formation do not block tetramer formation (Dong et al., 1999) , with the mutant tetramer retaining repressor activity, albeit reduced, possibly owing to reduced tetramer stability (Dong et al., 1999) . Presumably, this explains the greater negative impact of the G192D vs F147S mutation on NfxB repressor function -the former blocks formation of the active tetrameric repressor, while the latter only reduces this. The fact that EMSAs revealed an oligomeric DNAbinding form for NfxB F147S while the two-hybrid assay showed no evidence of oligomerization likely reflects the limitations of the latter assay, which is unable to detect weaker interactions that are, nonetheless, sufficient to produce a partially functional oligomeric repressor. In this vein, it is interesting to note that the G166D mutation, which yielded an NfxB variant that showed evidence of oligomerization in the two-hybrid assay and EMSA, failed to yield oligomers as assessed using size-exclusion chromatography. Given the relatively small proportion of wildtype NfxB that forms tetramers in solution and the negative impact of the G166D mutation on active tetrameric repressor formation (as assessed using EMSA) it may simply be that the tetramer yield for purified NfxB G166D passaged across a size-exclusion column is below the detection limit of the system. This mutation has the smallest negative impact on NfxB repressor activity of all the mutations here studied, providing for an approximate 30-fold increase in mexCD-oprJ expression. This is consistent with the mutation not directly disrupting the HTH DNA-binding domain and only modestly impacting NfxB oligomerization.
